CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,910 | -34.5% | 207,329 | -2.6% | 0.00% | – |
| Q3 2022 | $35,000 | -34.0% | 212,834 | 0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -53.1% | 212,834 | -0.2% | 0.00% | – |
| Q1 2022 | $113,000 | -14.4% | 213,222 | -0.2% | 0.00% | – |
| Q4 2021 | $132,000 | -40.5% | 213,597 | -1.9% | 0.00% | – |
| Q3 2021 | $222,000 | -43.1% | 217,665 | +2.0% | 0.00% | – |
| Q2 2021 | $390,000 | -75.2% | 213,327 | -73.2% | 0.00% | – |
| Q1 2021 | $1,571,000 | +51.8% | 797,449 | -3.7% | 0.00% | – |
| Q4 2020 | $1,035,000 | -31.1% | 827,845 | -0.9% | 0.00% | – |
| Q3 2020 | $1,503,000 | -77.0% | 835,196 | +7.0% | 0.00% | -100.0% |
| Q2 2020 | $6,546,000 | +57.7% | 780,199 | -1.5% | 0.00% | +100.0% |
| Q1 2020 | $4,151,000 | +9.3% | 792,181 | +13.9% | 0.00% | 0.0% |
| Q4 2019 | $3,799,000 | +12.8% | 695,751 | +0.7% | 0.00% | 0.0% |
| Q3 2019 | $3,367,000 | -20.3% | 691,254 | +13.3% | 0.00% | 0.0% |
| Q2 2019 | $4,227,000 | -3.5% | 610,088 | -3.2% | 0.00% | 0.0% |
| Q1 2019 | $4,379,000 | +27.7% | 630,089 | +7.3% | 0.00% | 0.0% |
| Q4 2018 | $3,428,000 | -23.8% | 586,989 | -1.4% | 0.00% | 0.0% |
| Q3 2018 | $4,496,000 | +55.6% | 595,493 | +4.0% | 0.00% | 0.0% |
| Q2 2018 | $2,890,000 | -10.9% | 572,325 | +7.6% | 0.00% | 0.0% |
| Q1 2018 | $3,245,000 | -12.8% | 531,969 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $3,722,000 | +3.8% | 524,154 | +4.5% | 0.00% | 0.0% |
| Q3 2017 | $3,587,000 | +18.0% | 501,775 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $3,039,000 | +598.6% | 482,337 | +814.3% | 0.00% | – |
| Q1 2017 | $435,000 | +13.6% | 52,753 | +16.4% | 0.00% | – |
| Q4 2016 | $383,000 | +23.9% | 45,318 | -0.3% | 0.00% | – |
| Q3 2016 | $309,000 | +221.9% | 45,436 | +41.0% | 0.00% | – |
| Q2 2016 | $96,000 | +108.7% | 32,214 | +26.4% | 0.00% | – |
| Q1 2016 | $46,000 | +9.5% | 25,490 | 0.0% | 0.00% | – |
| Q4 2015 | $42,000 | +5.0% | 25,490 | 0.0% | 0.00% | – |
| Q3 2015 | $40,000 | +17.6% | 25,490 | +131.8% | 0.00% | – |
| Q2 2015 | $34,000 | – | 10,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |